Amperi 5mg Solution for injection

Amperi 5mg Solution for injection

S5


Clinical Summary

Quick overview from the medicine insert

Indication

Management of acute and chronic psychotic disorders, including schizophrenia and acute mania.

Dosage (summary)

Initial dose of 2 to 5 mg, administered intramuscularly or intravenously. Maintenance doses may vary based on clinical response.

Onset of Action / Duration

Onset of action is typically within 30 to 60 minutes; duration of effect may last 4 to 8 hours.

Special Populations

  • Elderly patients
  • Patients with hepatic impairment
  • Patients with renal impairment

Pregnancy & Breastfeeding

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Haloperidol is excreted in breast milk; caution is advised when administered to nursing mothers.

Key Drug Interactions

  • CNS depressants may enhance sedative effects.
  • Anticholinergic drugs may increase the risk of side effects.
  • Drugs that prolong QT interval may increase the risk of arrhythmias.

Contraindications

  • Hypersensitivity to haloperidol or any component of the formulation.
  • Severe central nervous system depression.
  • Parkinson's disease.

Common side effects

  • Extrapyramidal symptoms (EPS)
  • Sedation
  • Weight gain
  • Anticholinergic effects (dry mouth, constipation)
  • QT prolongation

Counselling Points

  • Advise patients to report any unusual movements or symptoms of EPS.
  • Instruct patients to avoid alcohol while taking this medication.
  • Inform patients about the potential for sedation and to avoid driving or operating heavy machinery until they know how the medication affects them.

Serious warnings

  • Monitor for signs of tardive dyskinesia, especially in long-term use.
  • Use with caution in patients with a history of seizures.
  • Risk of neuroleptic malignant syndrome (NMS), a potentially life-threatening condition.
Important Disclaimer

The Amperi 5mg Solution for injection professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites